Elevated expression levels of SDC3 have been reported in bladder and ovarian cancer, and renal cell carcinoma [115,116,117], whereas low levels of SDC3, SDC4, GPC1, and GPC3 are expressed in neuroblastoma [35]. The gene discussed is GPC3; the disease is ovarian carcinoma.